Year: 2020

MCLEAN, Va., Nov. 09, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are multifamily mortgage-backed securities. The company expects to issue approximately $767 million in K Certificates (K-1518 Certificates), which are expected to settle on or about November 17, 2020.K-1518 PricingDetailsCo-Lead Managers and Joint Bookrunners: PNC Capital Markets LLC and Morgan Stanley & Co. LLCCo-Managers: Brean Capital, LLC, Credit Suisse Securities (USA) LLC, Stern Brothers & Co. and Wells Fargo Securities, LLCRelated LinksThe K-1518 Preliminary Offering Circular Supplement: http://www.freddiemac.com/mbs/data/0k1518oc.pdfFreddie Mac Multifamily Securitization OverviewMultifamily Securities Investor Access database of post-securitization...

COLUMBIA, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) — W. R. Grace & Co. (NYSE: GRA) today confirmed that it has received a proposal from 40 North Management LLC (“40 North”), one of its shareholders, to acquire all outstanding common shares of the Company for $60 per share in cash, subject to certain conditions.Grace has a portfolio of high-value, specialty businesses and while end markets have been significantly impacted by the pandemic, the fundamentals of its businesses remain strong and demand trends continue to improve. As the Company has communicated, most recently on its third quarter 2020 earnings call, Grace has often pursued opportunities to maximize shareholder value.Consistent with its commitment to all shareholders, Grace’s Board, working with management and its financial advisers, is carefully evaluating and thoroughly...

– Data support continued development of ADP-A2M4CD8 –– On track to start Phase 2 trial in gastroesophageal cancers in the first half of 2021 –PHILADELPHIA, Pa. and OXFORDSHIRE, UK., Nov. 09, 2020 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in cell therapy to treat cancer, presented data from the dose escalation cohorts of its Phase 1 SURPASS trial using ADP-A2M4CD8 in a poster at the Society for the Immunotherapy of Cancer (“SITC”) Conference.In these cohorts of heavily pre-treated patients with advanced cancers (n=6), three were treated with target doses of 1 billion SPEAR T-cells, and three with target doses of 5 billion. Most adverse events were consistent with those typically experienced by cancer patients undergoing cytotoxic chemotherapy or cancer immunotherapy.“We have...

RALEIGH, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) — First Citizens Bank announced that its Gwinnett Community Bank division based in Duluth, Ga., has completed its conversion to First Citizens’ operations and systems. This conversion aligns customer accounts to First Citizens products and services and puts both banks on the same operational and technical systems.“We’re pleased to officially welcome Gwinnett Community Bank customers to First Citizens, and our associates are ready and prepared to provide them with outstanding service,” said Frank B. Holding Jr., chairman and CEO of First Citizens Bank. “We look forward to deepening our relationships with new and current clients and continuing to grow in Georgia.”Effective today (Nov. 9), three former Gwinnett Community division branches in Georgia now carry the First Citizens Bank name....

Worldline holds more than 93% of the share capital and voting rights of Ingenico following the reopening of its friendly tender offerOwnership by Worldline following the reopening of the offer:            93.91% of Ingenico’s share capital, representing at least 93.05% of voting rights1            99,64% of OCEANEs in circulationWorldline will request the implementation of a squeeze-outBezons and Paris, November 9, 2020Following the publication today by the Autorité des marchés financiers (AMF) of the final results of Worldline’s friendly tender offer for Ingenico securities, Worldline and Ingenico announce that, following settlement of the reopened offer, which will take place on November 17, 2020, Worldline will hold 59,835,692 Ingenico shares, representing 93.91% of the share capital and at least 93.05% of the voting rights1...

Worldline détient plus de93% du capital et des droits de vote d’Ingenicoà l’issue de la réouverturede son offre publique amicaleDétention par Worldline à l’issue de la réouverture de l’offre :93,91% du capital représentant au moins 93,05% des droits de vote d’Ingenico199,64% des OCEANEs en circulationWorldline demandera la mise en œuvre d’une procédure de retrait obligatoireBezons et Paris, le 9 novembre 2020Suite à la publication ce jour par l’Autorité des marchés financiers des résultats définitifs de l’offre publique amicale de Worldline portant sur les titres Ingenico, Worldline et Ingenico annoncent qu’à l’issue du règlement-livraison de l’offre réouverte, qui interviendra le 17 novembre 2020, Worldline détiendra 59.835.692 actions Ingenico, représentant 93,91% du capital et au moins 93,05% des droits de vote1 et 2.893.994 OCEANEs...

Worldline holds more than 93% of the share capital and voting rights of Ingenico following the reopening of its friendly tender offerOwnership by Worldline following the reopening of the offer:            93.91% of Ingenico’s share capital, representing at least 93.05% of voting rights1            99,64% of OCEANEs in circulationWorldline will request the implementation of a squeeze-outBezons and Paris, November 9, 2020Following the publication today by the Autorité des marchés financiers (AMF) of the final results of Worldline’s friendly tender offer for Ingenico securities, Worldline and Ingenico announce that, following settlement of the reopened offer, which will take place on November 17, 2020, Worldline will hold 59,835,692 Ingenico shares, representing 93.91% of the share capital and at least 93.05% of the voting rights1...

Worldline détient plus de93% du capital et des droits de vote d’Ingenicoà l’issue de la réouverturede son offre publique amicaleDétention par Worldline à l’issue de la réouverture de l’offre :93,91% du capital représentant au moins 93,05% des droits de vote d’Ingenico199,64% des OCEANEs en circulationWorldline demandera la mise en œuvre d’une procédure de retrait obligatoireBezons et Paris, le 9 novembre 2020Suite à la publication ce jour par l’Autorité des marchés financiers des résultats définitifs de l’offre publique amicale de Worldline portant sur les titres Ingenico, Worldline et Ingenico annoncent qu’à l’issue du règlement-livraison de l’offre réouverte, qui interviendra le 17 novembre 2020, Worldline détiendra 59.835.692 actions Ingenico, représentant 93,91% du capital et au moins 93,05% des droits de vote1 et 2.893.994 OCEANEs...

Phase-III-Studie TRYbeCA-1 zur Zweitlinienbehandlung bei metastasierendem Pankreaskrebs:Mehr als 95 % der ca. 500 Patienten wurden bereits aufgenommenAnzahl der erforderlichen Ereignisse für die Interims-Überlegenheitsanalyse wurde erreichtInterims-Überlegenheitsanalyse wird voraussichtlich im ersten Quartal 2021 durchgeführtVon der NOPHO gesponserte Phase-II-Studie zur Behandlung von akuter lymphoblastischer Leukämie:Rekrutierung der Patienten ist abgeschlossen: Aufnahme von 55 PatientenTopline-Endergebnisse für eine mündliche Präsentation auf der Jahrestagung der ASH im Dezember 2020 ausgewähltErnennung von Stewart Craig zum Chief Technical OfficerZahlungsmittel und Zahlungsmitteläquivalente in Höhe von 40,5 Mio. Euro (47,5 Mio. US-Dollar) Ende September 2020Nicht-verwässernde Finanzierung in Höhe von 10 Mio. Euro (11,7 Mio. US-Dollar)...

Studio di fase 3 TRYbeCA-1 sul trattamento di seconda linea per il carcinoma pancreatico metastatico:È stato arruolato oltre il 95% dei circa 500 pazienti previstiIl numero di eventi richiesti per l’analisi di superiorità ad interim è stato raggiuntoSi prevede che i risultati dell’analisi di superiorità ad interim vengano pubblicati nel primo trimestre del 2021Studio di fase 2 sponsorizzato da NOPHO sulla leucemia linfoblastica acuta:Arruolamento dei pazienti completato: arruolati 55 pazientiDati finali generali selezionati per essere presentati verbalmente in occasione dell’ASH a dicembre 2020Nomina del Dr. Stewart Craig come Chief Technical OfficerDisponibilità liquide e mezzi equivalenti pari a € 40,5 milioni ($ 47,5 milioni) a fine settembre 2020€ 10 milioni ($ 11,7 milioni) in finanziamenti non diluitivi sotto forma di prestiti garantiti...